Ligand validation:2YMD

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YMD_GOL_F_1215	74%	82%	0.113	0.943	0.36	0.43	-	-	0	0	100%	1
2YMD_GOL_B_1211	74%	90%	0.119	0.949	0.33	0.28	-	-	0	0	100%	1
2YMD_GOL_F_1213	73%	82%	0.122	0.948	0.35	0.44	-	-	3	0	100%	1
2YMD_GOL_C_1214	60%	74%	0.144	0.931	0.38	0.62	-	-	0	0	100%	1
2YMD_GOL_D_1213	58%	80%	0.147	0.927	0.36	0.49	-	-	0	0	100%	1
2YMD_GOL_E_1214	56%	86%	0.163	0.935	0.36	0.35	-	-	0	0	100%	1
2YMD_GOL_B_1213	49%	83%	0.177	0.925	0.36	0.42	-	-	3	0	100%	1
2YMD_GOL_J_1215	40%	86%	0.144	0.852	0.35	0.38	-	-	4	0	100%	1
2YMD_GOL_B_1215	39%	73%	0.16	0.866	0.37	0.68	-	-	4	0	100%	1
2YMD_GOL_A_1214	37%	62%	0.15	0.846	0.43	0.99	-	-	4	0	100%	1
2YMD_GOL_F_1217	31%	82%	0.224	0.893	0.4	0.4	-	-	1	0	100%	1
2YMD_GOL_D_1216	23%	86%	0.186	0.81	0.35	0.38	-	-	2	0	100%	1
2YMD_GOL_G_1215	20%	91%	0.201	0.8	0.41	0.18	-	-	2	0	100%	1
2YMD_GOL_D_1215	16%	85%	0.245	0.811	0.32	0.42	-	-	2	0	100%	1
6T9R_GOL_FFF_303	68%	69%	0.117	0.929	0.4	0.77	-	-	0	0	100%	1
4FRR_GOL_A_304	65%	79%	0.112	0.913	0.46	0.4	-	-	0	0	100%	1
2Y56_GOL_B_701	31%	62%	0.23	0.898	0.91	0.56	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.